Document Detail


Prevention of developmental abnormalities with particular emphasis of primary prevention.
MedLine Citation:
PMID:  12442549     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The Hungarian total (birth + fetal) prevalences of different developmental abnormalities offer a possibility to estimate the proportion of preventable development abnormalities. The effectiveness of primary, secondary and tertiary preventive methods are evaluated with a particular emphasis of primary prevention based on periconceptional folic acid or folic acid-containing multivitamin supplementation. The total prevalence of informative offspring with developmental abnormalities is 66.83 per 1,000 in Hungary and within this major DAs have 27.01 per 1,000 rate. The latter can be reduced by 26.6% by primary preventive methods due to mainly periconceptional folic acid/multivitamin supplementation. Secondary prevention particularly neonatal orthopedic screening is very effective for deformities such as congenital dislocation of the hip. Antenatal diagnoses followed by termination of pregnancy can avoid the birth of malformed newborn infants in 8.7% of DAs, however, this figure is 20 and 27% among major and multiple developmental abnormalities, respectively. Early surgical intervention can achieve a complete recovery in 33.5% of cases with developmental abnormalities. Thus there are two major conclusions: at present the major part of developmental abnormalities are preventable, however, different developmental abnormalities do not represent a single pathological category therefore there is no single strategy for their prevention.
Authors:
E Czeizel
Related Documents :
12768409 - Impact of public health strategies on the birth prevalence of cystic fibrosis in britta...
12204419 - Advances in prenatal screening for down syndrome: ii first trimester testing, integrate...
10419619 - Maternal serum prostate-specific antigen and down syndrome in the first and second trim...
24720599 - The impact of metabolic disease associated with metabolic syndrome on human pregnancy.
18760229 - Prenatal diagnosis and genetic screening--integration into prenatal care.
10589049 - Comparison of nuchal translucency measurement and mid-gestation serum screening in assi...
2191069 - Diagnosis of placenta previa by ultrasonography: a review at ramathibodi hospital.
17533489 - Spectrophotometric analysis of melanocytic naevi during pregnancy.
6476479 - Paroxysmal ventricular tachycardia associated with bell's palsy in a teenager at late p...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  T͡Sitologii͡a i genetika     Volume:  36     ISSN:  0564-3783     ISO Abbreviation:  Tsitol. Genet.     Publication Date:    2002 Sep-Oct
Date Detail:
Created Date:  2002-11-21     Completed Date:  2003-01-22     Revised Date:  2008-02-15    
Medline Journal Info:
Nlm Unique ID:  0101671     Medline TA:  Tsitol Genet     Country:  Ukraine    
Other Details:
Languages:  eng     Pagination:  58-72     Citation Subset:  IM    
Affiliation:
Foundation for the Community Control of Hereditary Diseases, Budapest, Hungary.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Congenital Abnormalities / epidemiology,  genetics,  prevention & control*
Dietary Supplements*
Female
Folic Acid / administration & dosage*
Genetic Counseling
Humans
Hungary / epidemiology
Infant, Newborn
Pregnancy
Prenatal Diagnosis
Prevalence
Chemical
Reg. No./Substance:
59-30-3/Folic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Evolution of mitochondria
Next Document:  Role of Yq11-chromosome microdeletion in the development of nonobstructive infertility in men